These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8806569)

  • 1. The immunogenic and pathogenic potential of short poly(C) tract Mengo viruses.
    Osorio JE; Martin LR; Palmenberg AC
    Virology; 1996 Sep; 223(2):344-50. PubMed ID: 8806569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of Mengo virus through genetic engineering of the 5' noncoding poly(C) tract.
    Duke GM; Osorio JE; Palmenberg AC
    Nature; 1990 Feb; 343(6257):474-6. PubMed ID: 2153940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virus.
    Osorio JE; Hubbard GB; Soike KF; Girard M; van der Werf S; Moulin JC; Palmenberg AC
    Vaccine; 1996 Feb; 14(2):155-61. PubMed ID: 8852413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of genetically engineered mengoviruses in mice.
    Osorio JE; Grossberg SE; Palmenberg AC
    Viral Immunol; 2000; 13(1):27-35. PubMed ID: 10733166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A wild-type porcine encephalomyocarditis virus containing a short poly(C) tract is pathogenic to mice, pigs, and cynomolgus macaques.
    LaRue R; Myers S; Brewer L; Shaw DP; Brown C; Seal BS; Njenga MK
    J Virol; 2003 Sep; 77(17):9136-46. PubMed ID: 12915530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does physiological interferon play a role in Mengo virus infection of mice?
    Błach-Olszewska Z; Veckenstedt A; Zaczyńska E
    Acta Virol; 1993 Feb; 37(1):68-72. PubMed ID: 7692712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mengovirus and encephalomyocarditis virus poly(C) tract lengths can affect virus growth in murine cell culture.
    Martin LR; Neal ZC; McBride MS; Palmenberg AC
    J Virol; 2000 Apr; 74(7):3074-81. PubMed ID: 10708422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the mengovirus poly(C) tract and surrounding heteropolymeric sequences.
    Martin LR; Duke GM; Osorio JE; Hall DJ; Palmenberg AC
    J Virol; 1996 Mar; 70(3):2027-31. PubMed ID: 8627731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against lethal encephalomyocarditis virus infection in the absence of serum-neutralizing antibodies.
    Neal ZC; Splitter GA
    J Virol; 1998 Oct; 72(10):8052-60. PubMed ID: 9733845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
    Pletnev AG
    Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T cell response to Mengo virus in mice: effector cell phenotype and target proteins.
    Escriou N; Leclerc C; Gerbard S; Giraud M; van der Werf S
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1999-2007. PubMed ID: 7636480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encephalomyocarditis viruses with short poly(C) tracts are more virulent than their mengovirus counterparts.
    Hahn H; Palmenberg AC
    J Virol; 1995 Apr; 69(4):2697-9. PubMed ID: 7884926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and synthesis of infectious cardiovirus RNAs containing short, discrete poly(C) tracts.
    Duke GM; Palmenberg AC
    J Virol; 1989 Apr; 63(4):1822-6. PubMed ID: 2538661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioviral poly(C) tracts and viral pathogenesis.
    Palmenberg AC; Osorio JE
    Arch Virol Suppl; 1994; 9():67-77. PubMed ID: 8032283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
    Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
    Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations.
    Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X
    Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of endogenous viral polymerase, 3D(pol), in preparations of Mengo and encephalomyocarditis viruses.
    Frolov VG; Duque H; Palmenberg AC
    Virology; 1999 Jul; 260(1):148-55. PubMed ID: 10405366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Virulence comparison of genetic engineering virus containing different length poly(C) tract of foot-and-mouth disease virus].
    Bai X; Li P; Sun P; Li Y; Bao H; Lu Z; Cao Y; Guo J; Liu Z
    Wei Sheng Wu Xue Bao; 2008 Dec; 48(12):1654-8. PubMed ID: 19274849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response.
    Brandt T; Heck MC; Vijaysri S; Jentarra GM; Cameron JM; Jacobs BL
    Virology; 2005 Mar; 333(2):263-70. PubMed ID: 15721360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.